Correlation Between Palantir Technologies and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both Palantir Technologies and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palantir Technologies and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palantir Technologies Class and Regen BioPharma, you can compare the effects of market volatilities on Palantir Technologies and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palantir Technologies with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palantir Technologies and Regen BioPharma.
Diversification Opportunities for Palantir Technologies and Regen BioPharma
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Palantir and Regen is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Palantir Technologies Class and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Palantir Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palantir Technologies Class are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Palantir Technologies i.e., Palantir Technologies and Regen BioPharma go up and down completely randomly.
Pair Corralation between Palantir Technologies and Regen BioPharma
Given the investment horizon of 90 days Palantir Technologies is expected to generate 2.42 times less return on investment than Regen BioPharma. But when comparing it to its historical volatility, Palantir Technologies Class is 5.15 times less risky than Regen BioPharma. It trades about 0.12 of its potential returns per unit of risk. Regen BioPharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 92.00 in Regen BioPharma on August 31, 2024 and sell it today you would lose (86.00) from holding Regen BioPharma or give up 93.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.73% |
| Values | Daily Returns |
Palantir Technologies Class vs. Regen BioPharma
Performance |
| Timeline |
| Palantir Technologies |
| Regen BioPharma |
Palantir Technologies and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palantir Technologies and Regen BioPharma
The main advantage of trading using opposite Palantir Technologies and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palantir Technologies position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| Palantir Technologies vs. Palo Alto Networks | Palantir Technologies vs. Adobe Systems Incorporated | Palantir Technologies vs. Crowdstrike Holdings | Palantir Technologies vs. Block Inc |
| Regen BioPharma vs. Rigel Pharmaceuticals | Regen BioPharma vs. Geron | Regen BioPharma vs. Verastem | Regen BioPharma vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| CEOs Directory Screen CEOs from public companies around the world |